Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Masuda

Showing results (181-190 of 249) with videos related to

Pageof 25
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica|October 2, 2003
[Cyclophosphamide-induced bladder cancer: three case reports]Toshiki Kijima, Hitoshi Masuda, Masahito Suzuki, et al.
BJU International|February 28, 2019
Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patientsToshiki Kijima, Hajime Tanaka, Fumitaka Koga, et al.
European Urology|October 23, 2012
Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapyYoh Matsuoka, Noboru Numao, Kazutaka Saito, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 26, 2002
Intracavitary administration of OK-432 with subcutaneous priming for malignant ascites in a case of advanced renal cell carcinomaYukio Kageyama, Yasuyuki Sakai, Gaku Arai, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 21, 2023
The significance of SARC-F scores in predicting postoperative outcomes of older adults undergoing elective major surgery for urologic cancerShugo Yajima, Hiroshi Fukushima, Shioto Oda, et al.
Urologic Oncology|January 22, 2026
Pharmacologic synergy versus independent action in androgen receptor-axis-targeted agent-docetaxel triplet therapy for metastatic hormone-sensitive prostate cancer: a copula-based analysisWei Chen, Soichiro Yoshida, Shugo Yajima, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 17, 2013
Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancerShuichiro Kobayashi, Fumitaka Koga, Kohei Kajino, et al.
Urologic Oncology|April 9, 2013
Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinomaShinji Urakami, Yasuhisa Fujii, Shinya Yamamoto, et al.
European Urology|January 22, 2008
Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsySatoru Kawakami, Noboru Numao, Yuhei Okubo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 14, 2022
Outcomes of artificial urinary sphincter implantation in patients with diabetes mellitus: A subgroup analysisYasuhiro Kaiho, Hitoshi Masuda, Mineo Takei, et al.
Pageof 25

Showing results (181-190 of 249) with videos related to

Sort By:
Pageof 25
Hinyokika Kiyo. Acta Urologica Japonica|October 2, 2003
[Cyclophosphamide-induced bladder cancer: three case reports]Toshiki Kijima, Hitoshi Masuda, Masahito Suzuki, et al.
BJU International|February 28, 2019
Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patientsToshiki Kijima, Hajime Tanaka, Fumitaka Koga, et al.
European Urology|October 23, 2012
Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapyYoh Matsuoka, Noboru Numao, Kazutaka Saito, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 26, 2002
Intracavitary administration of OK-432 with subcutaneous priming for malignant ascites in a case of advanced renal cell carcinomaYukio Kageyama, Yasuyuki Sakai, Gaku Arai, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 21, 2023
The significance of SARC-F scores in predicting postoperative outcomes of older adults undergoing elective major surgery for urologic cancerShugo Yajima, Hiroshi Fukushima, Shioto Oda, et al.
Urologic Oncology|January 22, 2026
Pharmacologic synergy versus independent action in androgen receptor-axis-targeted agent-docetaxel triplet therapy for metastatic hormone-sensitive prostate cancer: a copula-based analysisWei Chen, Soichiro Yoshida, Shugo Yajima, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 17, 2013
Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancerShuichiro Kobayashi, Fumitaka Koga, Kohei Kajino, et al.
Urologic Oncology|April 9, 2013
Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinomaShinji Urakami, Yasuhisa Fujii, Shinya Yamamoto, et al.
European Urology|January 22, 2008
Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsySatoru Kawakami, Noboru Numao, Yuhei Okubo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 14, 2022
Outcomes of artificial urinary sphincter implantation in patients with diabetes mellitus: A subgroup analysisYasuhiro Kaiho, Hitoshi Masuda, Mineo Takei, et al.
Pageof 25